Dacogen and Pain in extremity - a phase IV clinical study of FDA data

Summary:

Pain in extremity is reported as a side effect among people who take Dacogen (decitabine), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Venclexta, and have Acute myeloid leukaemia.

The phase IV clinical study analyzes which people have Pain in extremity when taking Dacogen. It is created by eHealthMe based on reports of 1,535 people who have side effects when taking Dacogen from the FDA, and is updated regularly.

What is Dacogen?

Dacogen has active ingredients of decitabine. eHealthMe is studying from 1,541 Dacogen users. Check the latest studies of Dacogen.

What is Pain in extremity?

Pain in extremity is found to be associated with 3,224 drugs and 4,295 conditions by eHealthMe. Check the latest studies of Pain in extremity.

On Jul, 31, 2026

1,535 people reported to have side effects when taking Dacogen.
Among them, 22 people (1.43%) have Pain in extremity.

Among these 22 people:

How long have people been on Dacogen when they have Pain in extremity? *

What is the gender of people who have Pain in extremity when taking Dacogen? *

female: 59.09 %
male: 40.91 %

What is the age of people who have Pain in extremity when taking Dacogen? *

What are other drugs people take besides Dacogen? *

What are other side effects people have besides Pain in extremity? *

Weakness: 11 people, 50.00%
Fever: 9 people, 40.91%
Thrombocytopenia (decrease of platelets in blood): 8 people, 36.36%
Nausea (feeling of having an urge to vomit): 6 people, 27.27%
White Blood Cell Count Decreased: 5 people, 22.73%
Joint Pain: 5 people, 22.73%
Joint Swelling: 5 people, 22.73%
Chills (felling of cold): 4 people, 18.18%
Oedema Peripheral (superficial swelling): 4 people, 18.18%
Haemoglobin Abnormal: 4 people, 18.18%

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 8 people, 36.36%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 6 people, 27.27%
Bone Pain: 3 people, 13.64%
Depression: 3 people, 13.64%
Refractory Anaemia With An Excess Of Blasts (one or more cell types are low in the blood and look abnormal in the bone marrow): 2 people, 9.09%
Neuralgia (pain in one or more nerves): 2 people, 9.09%
Adverse Drug Reaction: 2 people, 9.09%
Micturition Disorder (disease of passing urine): 2 people, 9.09%
Joint Pain: 2 people, 9.09%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Dacogen and have Pain in extremity?

- Check whether Pain in extremity is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dacogen:

Dacogen (1,541 reports)

Pain in extremity treatments and more:

Pain in extremity (376,792 reports)

Browse all side effects of Dacogen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pain in extremity:

Pain in extremity (3,224 drugs)

Browse all the conditions that are associated with Pain in extremity:

Pain in extremity (4,295 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on decitabine (the active ingredients of Dacogen) and Dacogen (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.